692 related articles for article (PubMed ID: 22142401)
1. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.
Tian Q; Price ND; Hood L
J Intern Med; 2012 Feb; 271(2):111-21. PubMed ID: 22142401
[TBL] [Abstract][Full Text] [Related]
2. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory.
Hood L; Flores M
N Biotechnol; 2012 Sep; 29(6):613-24. PubMed ID: 22450380
[TBL] [Abstract][Full Text] [Related]
3. Revolutionizing medicine in the 21st century through systems approaches.
Hood L; Balling R; Auffray C
Biotechnol J; 2012 Aug; 7(8):992-1001. PubMed ID: 22815171
[TBL] [Abstract][Full Text] [Related]
4. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
5. Systems approaches to biology and disease enable translational systems medicine.
Hood L; Tian Q
Genomics Proteomics Bioinformatics; 2012 Aug; 10(4):181-5. PubMed ID: 23084773
[TBL] [Abstract][Full Text] [Related]
6. Predictive, personalized, preventive, participatory (P4) cancer medicine.
Hood L; Friend SH
Nat Rev Clin Oncol; 2011 Mar; 8(3):184-7. PubMed ID: 21364692
[TBL] [Abstract][Full Text] [Related]
7. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
8. Systems biology and p4 medicine: past, present, and future.
Hood L
Rambam Maimonides Med J; 2013 Apr; 4(2):e0012. PubMed ID: 23908862
[TBL] [Abstract][Full Text] [Related]
9. From -omics to personalized medicine in nephrology: integration is the key.
Pesce F; Pathan S; Schena FP
Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
[TBL] [Abstract][Full Text] [Related]
10. Clinical multi-omics strategies for the effective cancer management.
Yoo BC; Kim KH; Woo SM; Myung JK
J Proteomics; 2018 Sep; 188():97-106. PubMed ID: 28821459
[TBL] [Abstract][Full Text] [Related]
11. Preface on application of omics technologies in cancer biology and therapy.
Georgakilas AG
Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
[No Abstract] [Full Text] [Related]
12. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
13. Recent omics technologies and their emerging applications for personalised medicine.
Kim DH; Kim YS; Son NI; Kang CK; Kim AR
IET Syst Biol; 2017 Jun; 11(3):87-98. PubMed ID: 28518059
[TBL] [Abstract][Full Text] [Related]
14. Infection systems biology: from reactive to proactive (P4) medicine.
Bengoechea JA
Int Microbiol; 2012 Jun; 15(2):55-60. PubMed ID: 22847266
[TBL] [Abstract][Full Text] [Related]
15. Building a personalized medicine infrastructure at a major cancer center.
Meric-Bernstam F; Farhangfar C; Mendelsohn J; Mills GB
J Clin Oncol; 2013 May; 31(15):1849-57. PubMed ID: 23589548
[TBL] [Abstract][Full Text] [Related]
16. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Rodriguez H; Pennington SR
Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
[TBL] [Abstract][Full Text] [Related]
17. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
18. Personalized Management of Cardiovascular Disorders.
Jain KK
Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
20. RNA sequencing for research and diagnostics in clinical oncology.
Buzdin A; Sorokin M; Garazha A; Glusker A; Aleshin A; Poddubskaya E; Sekacheva M; Kim E; Gaifullin N; Giese A; Seryakov A; Rumiantsev P; Moshkovskii S; Moiseev A
Semin Cancer Biol; 2020 Feb; 60():311-323. PubMed ID: 31412295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
